Latuda (lah-TOO-dah, lurasidone) will soon compete in the crowded market of atypical antipsychotics

Latuda (lah-TOO-dah, lurasidone) will soon compete in the crowded market of atypical antipsychotics.

It's another once-daily oral option for treating schizophrenia.

Latuda seems to work as well as other atypicals...and might be better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote